menu

ReachMD

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

A Critical View of JUPITER

close
A Critical View of JUPITER
RestartResume
Choose a format
Media formats available:
Details
Presenters
Comments
  • Overview

    Results from the recent JUPITER trial demonstrated that high-sensitivity C-reactive protein tests were strikingly effective at identifying patients whose risk of cardiovascular events and mortality could be significantly lowered with statin treatment. But do these results warrant broader screening for C-reactive protein, as some suggest? Join host Dr. Larry Kaskel and Dr. Eliot Brinton as they critically examine the JUPITER trial and the potential limitations of those findings for primary care physicians and the use of statins. 

    Brought to you by:

    NLA logo

     

Facebook Comments

Recommended
Details
Presenters
Comments
  • Overview

    Results from the recent JUPITER trial demonstrated that high-sensitivity C-reactive protein tests were strikingly effective at identifying patients whose risk of cardiovascular events and mortality could be significantly lowered with statin treatment. But do these results warrant broader screening for C-reactive protein, as some suggest? Join host Dr. Larry Kaskel and Dr. Eliot Brinton as they critically examine the JUPITER trial and the potential limitations of those findings for primary care physicians and the use of statins. 

    Brought to you by:

    NLA logo

     

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio

Loading...

Programs 1/28/20